fbpx Skip to main content

Supporting Life Science Means Supporting Life

Watch the full video

COVID-19 Testing

Exclusive for Biocom Members

Return to Work

Coronavirus Resource Center


Biocom Member Spotlight: 10x Genomics

Read Biocom’s interview with 10x Genomics CEO, Serge Saxonov who explains how 10x Genomics is building tools that help researchers look deeper at the inner workings of biology to bring new insight.

Read More


Connected by Biocom

In the world of life science, connection is the key to discovery.
Biocom connects organizations to each other so they can collaborate and work smarter together. See how we’re empowering members with novel resources and networks so they can grow faster and work efficiently.

Learn More


Take advantage of 30+ RFP-vetted life science-related contracts.


Biocom Institute + Illumina Foundation: Genomic Discoveries
Learn More

Biocom Institute, Illumina and Illumina Foundation Partner to Bring Genomics Education to the Classroom

Testing Solutions
Learn More

Find exclusive testing solutions from Biocom’s Return to Work Taskforce

Biocom Member Spotlights
Learn More

Read interviews with leaders of Biocom member organization

2020 EIR
Learn More

View our 2020 California Life Science Economic Impact Report

“I have had the opportunity to give presentations to VCs and Pharma Venture Funds at several Venture Day events. These experiences have been very helpful with respect to meeting investors from outside the San Diego area and also for valuable feedback. This is an important Biocom program!”
Michael J. Newman, CEO, Decoy Biosystems
“The LSYL (Life Science Young Leaders) series is a terrific idea. It’s just easier to make meaningful connections among contemporaries and this series is a great platform for that. I look forward to the next one.”
Brendan McCarthy, Attorney, Gunderson Dettmer Stough Villeneuve Franklin & Hachigan
“I was impressed with Biocom’s DeviceFest & Digital Health Conference on August 29th, 2018. The conference had a balance view of content and discussion time with industry experts, which allowed us to have deeper introductory meetings, which will lead to deeper relationships with experts from all over North America. Great job by the planning committee and the management of Biocom.”
Dipak Shah, Board Member, Obsidio Therapeutics, Inc.


Subscribe to Biocom newsletters tailored to your interests.